Evidence map›Paper›PMID 35499038›Full record

ReviewFrontiers in toxicology2022

Maternal Paracetamol Intake During Pregnancy-Impacts on Offspring Reproductive Development.

Rieko Tadokoro-Cuccaro, Benjamin G Fisher, Ajay Thankamony, Ken K Ong, Ieuan A Hughes

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in toxicology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. EndoCompass Project: Environmental Endocrinology.Hormone research in paediatrics · 2025
    Review
  5. Review
  6. Decoction derived fromFrontiers in pharmacology · 2024
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Rieko Tadokoro-CuccaroDepartment of Paediatrics, University of Cambridge, Cambridge, United Kingdom.
Benjamin G FisherWellcome/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, United Kingdom.
Ajay ThankamonyCambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Ken K OngDepartment of Paediatrics, University of Cambridge, Cambridge, United Kingdom.
Ieuan A HughesDepartment of Paediatrics, University of Cambridge, Cambridge, United Kingdom.
University of Cambridge · GBCambridge University Hospitals NHS Foundation Trust · GBMRC Epidemiology Unit · GBWellcome/Cancer Research UK Gurdon Institute · GB

Funding

Medical Research Council G1001995Medical Research Council MC_UU_12015/2Wellcome Trust
6 · The paper itself

Abstract

Paracetamol (acetaminophen) is the preferred antipyretic/analgesic for pregnant women as it is believed there are no adverse fetal effects at the recommended dose. However, emerging evidence suggests that intrauterine paracetamol exposure may be associated with certain urogenital/reproductive disorders in the offspring. In this mini-review, we describe human fetal sex development and possible pharmacological mechanisms by which paracetamol may disrupt this process, including reduced testicular production of testosterone and/or insulin-like peptide 3. We then review the available epidemiological literature on associations between maternal paracetamol exposure and offspring sexual development. Three epidemiological studies have reported associations between maternal paracetamol intake and increased risk of cryptorchidism, although five others have not. None have found associations with hypospadias or penile length. Two out of three studies have reported a shorter anogenital distance (a marker of androgen action during the masculinisation programming window, ∼8-14 weeks of gestation) in male infants antenatally exposed to paracetamol. One study has described a dose-dependent relationship between maternal paracetamol consumption and earlier female (but not male) attainment of puberty. Such epidemiological analyses are complicated by various factors, including method of paracetamol exposure assessment (usually retrospective self-report), variation in diagnostic accuracy, selection bias, confounding by clinical indication, and demographic/genetic differences between geographically separated populations. There is an urgent need for stronger evidence in this area, from both relevant experimental studies and large, carefully-designed prospective studies. In the meantime, a precautionary attitude to gestational paracetamol usage should be considered as the evidence for clinically significant reproductive effects in humans is limited.

Indexed as

acetaminophenanogenital distanceendocrine disruptionfetal exposureparacetamolreproductive developmenttoxicology

Identifiers

PMID35499038
PMCPMC9047911
OpenAlexW4224058184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.